Distribution of IgG subclasses after anti-hepatitis B virus immunization with a recombinant vaccine

International Journal of Clinical and Laboratory Research

Volumn 27, Issue 2, 1997, Pages 202-206

  Honorati, M C ^a,b   Borzi R M ^b   Dolzani, P ^b   Toneguzzi, S ^b   Facchini, A ^a,b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

Author keywords

Hepatitis B virus surface antigen; IgG subclasses; Recombinant vaccine

Indexed keywords

HEPATITIS B VIRUS;

EID: 0030799828     PISSN: 09405437     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf02912459     Document Type: Article

References (26)

1. Hamilton RG. Properties of the human IgG subclasses. In: The human IgG subclasses. La Jolla, California: Calbiochem: 1989: pp 5-10.
2. Shakib F. Basic and clinical aspects of human IgG subclasses. Monogr Allergy 1986; 19:1.
3. Falconer AE, Carson R, Johnstone R, Bird P, Kehoe M, Calvert JE. Distinct IgG1 and IgG3 subclass responses to two streptococcal protein antigens in man: analysis of antibodies to streptolysin O and M protein using standardized subclass-specific enzyme-linked immunosorbent assays. Immunology 1993; 79:89.
4. Yount WJ, Dorner MM, Kunkel HG, Kabat EA. Studies on human antibodies. VI. Selective variations in subgroup composition and genetic markers. J Exp Med 1968; 127:633.
5. Kaniuk AS, Lortan JE, Monteil MA. Specific IgG subclass antibody levels and phagocytosis of serotype 14 pneumococcus following immunization. Scand J Immunol 1992; 36 Suppl 11:96.
6. Elovaara I, Albert PS, Ranki A, Krohn K, Seppälä I. HIV-1 specificity of cerebrospinal fluid and serum IgG, IgM, and IgG1-G4 antibodies in relation to clinical disease. J Neurol Sci 1993; 117:111.
7. Urban M, Winkler T, Landini MP, Britt W, Mach M. Epitope-specific distribution of IgG subclasses against antigenic domains on glycoproteins of human cytomegalovirus. J Infect Dis 1994; 169:83.
8. Sällberg M, Norder H, Lindh G, Magnius LO. IgG subclasses in circulating immune complexes with hepatitis B e antigen in chronic hepatitis B. Clin Exp Immunol 1991; 84:116.
9. Akbar SMF, Horiike N, Onji M, Ohta Y. Immunoglobulin G subclasses of antibodies to hepatitis B core antigen in HBs antigen positive liver diseases. J Gastroenterol Hepatol 1991; 6:71.
10. Rath S, Devey ME. IgG subclass composition of antibodies to HBsAg in circulating immune complexes from patients with hepatitis B virus infections. Clin Exp Immunol 1988; 72:164.
11. Persson MAA, Brown SE, Steward MW, et al. IgG subclass-associated affinity differences of specific antibodies in humans. J Immunol 1988; 140:3875.
12. Mattila PS, Pelkonen J, Mäkelä O. Proportions of IgG subclasses in antibodies formed during vaccination with hepatitis B surface antigen. Scand J Immunol 1986; 24:699.
13. Rossi ME, Azzari C, Resti M, Appendino C, Pezzati P, Vierucci A. Selectivity in IgG subclass response to hepatitis B vaccine in infants born to HBsAg-positive mothers. Clin Exp Immunol 1988; 72:196.
14. Jilg W, Lorbeer B, Schmidt M, Wilske B, Zoulek G, Deinhardt F. Clinical evaluation of a recombinant hepatitis B vaccine. Lancet 1984; II:1174.
15. Andrè FE, Safary A. Clinical experience with a yeast-derived hepatitis B vaccine. In: Zuckerman AJ, ed. Viral hepatitis and liver disease. New York: Liss; 1988:1025-1030.
16. Jilg W, Deinhardt F. Results of immunization with a recombinant yeast-derived hepatitis B vaccine. J Infect 1986; 13 Suppl A:47.
17. Hollinger FB, Adam E, Heiberg D, Melnick JL. Response to hepatitis B vaccine in a young adult population. In: Szmuness W, Alter HJ, Maynard JE, eds. Viral hepatitis. Philadelphia: Franklin Institute; 1982:451-456.
18. Borzì RM, Dal Monte P, Honorati MC, Facchini A. IgG subclass distribution of anti-HBs antibodies following vaccination with cDNA HBsAg. J Immunol Methods 1992; 146:17.
19. Barnaba V, Franco A, Paroli M, et al. Selective expansion of cytotoxic T lymphocytes with a CD4+CD56+ surface phenotype and a T helper type 1 profile of cytokine secretion in the liver of patients chronically infected with hepatitis B virus. J Immunol 1994; 152:3074.
20. Soiffer RJ, Murray C, Ritz J, et al. Recombinant interleukin-2 infusions and decreased IgG2 subclass concentrations. Blood 1995; 85:925.
21. Gillis S, Kozak R, Durante M, Weksler ME. Immunological studies of ageing. Decreased production of and response to T cell growth factor by lymphocytes from aged humans. J Clin Invest 1981; 67:937.
22. Jackola DR, Ruger JK, Miller RA. Age-associated changes in human T cell phenotype and function. Aging Clin Exp Res 1993; 6:25.
23. Paganelli R, Scala E, Quinti I, Ansotegui IJ. Humoral immunity in aging. Aging Clin Exp Res 1994; 6:143.
24. Hsu HY, Chang MH, Ho HN, et al. Association of HLA-DR14-DR52 with low responsiveness to hepatitis B vaccine in Chinese resident in Taiwan. Vaccine 1993; 11:1437.
25. Craven DE, Awdeh ZL, Kunches LM, Yunis EJ, Dienstag JL, Werner BG. Nonresponsiveness to hepatitis B vaccine in health care workers: results of revaccination and genetic typings. Ann Intern Med 1986; 105:356.
26. Alper CA, Kruskall MS, Marcus-Bagley D, et al. Genetic prediction of nonresponse to hepatitis B vaccine. N Engl J Med 1989; 321:708.